Stocklytics Platform
Asset logo for symbol ANIK
Anika Therapeutics
ANIK53
$17.86arrow_drop_up1.30%$0.23
Asset logo for symbol ANIK
ANIK53

$17.86

arrow_drop_up1.30%
Key Stats
Open$17.75
Prev. Close$17.65
EPS-6.64
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range16.52
18.95
52 Week Range14.61
29.12
Ratios
EPS-6.64
Fundamentals
Payout Ratio-
Industry average yield2.98%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

ANIK-
US Healthcare Sector-
US Market-
check_circle

ANIK / Market

ANIK exceeded the US Market which returned -0.15% over the last twenty four hours.
check_circle

ANIK / Healthcare Sector

ANIK exceeded the US Healthcare sector which returned 1.08% over the last twenty four hours.

Anika Therapeutics (ANIK) Statistics

Anika Therapeutics Inc (ANIK) is a leading global medical technology company that develops and commercializes innovative treatments for tissue protection, healing, and repair. The company's products are primarily focused on orthopedic, surgical, and regenerative medicine markets. With a strong commitment to improving patient outcomes, Anika Therapeutics has established itself as a trusted provider of advanced medical solutions.
When it comes to stock statistics, Anika Therapeutics Inc (ANIK) has been performing consistently well. The company's stock has shown impressive growth over the years, outperforming the sector average. Its valuation metrics also indicate a positive outlook, with strong fundamentals supporting its market position. ANIK's enterprise to EBITDA ratio, a key valuation metric, is favorable, signaling a healthy financial performance.
add Anika Therapeutics  to watchlist

Keep an eye on Anika Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Anika Therapeutics (ANIK) stock's performance compared to its sector and the market over the past year?

Over the past year, Anika Therapeutics (ANIK) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 17.95%, Anika Therapeutics has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 39.25%, it has fallen short of the market average. This comparison highlights Anika Therapeutics 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Anika Therapeutics (ANIK) stock?

The PE ratio for Anika Therapeutics (ANIK) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Anika Therapeutics (ANIK) stock?

The Earnings Per Share (EPS) for Anika Therapeutics (ANIK), calculated on a diluted basis, is -$6.64. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Anika Therapeutics (ANIK) stock?

The operating margin for Anika Therapeutics (ANIK) is -64.29%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Anika Therapeutics (ANIK) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Anika Therapeutics (ANIK) is $50.96M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Anika Therapeutics (ANIK) have?

Anika Therapeutics (ANIK) has a total debt of $27.53M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$34.83M.

Take Your Investments to a Whole New Level